Navigation Links
ETC Biomedical Announces Chamber Sale in India
Date:8/4/2009

SOUTHAMPTON, Pa., Aug. 4 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation's (OTC Bulletin Board: ETCC) ("ETC" or the "Company") BioMedical Systems Division has been contracted with Hospimedica International Pvt. Ltd. for the delivery and installation of one BARA-MED((R)) monoplace hyperbaric chamber. The chamber was sold through ETC's local distributor, Hospimedica International Pvt. Ltd.

Hospimedica International Pvt. Ltd. has over 20 years experience in the field of medical equipment. Hospimedica is one of India's top suppliers of medical equipment, representing a long list of world-class medical equipment manufacturers.

The order is for one (1) BARA-MED((R)) hyperbaric oxygen therapy chamber. The BARA-MED features ETC's Smooth Ride(TM) technology while helping our customers minimize oxygen consumption. The system will also incorporate ETC's 4(th) generation Windows(TM) based operating system that eliminates manual recordkeeping and facilitates Electronic Medical Recordkeeping (EMR).

Don Webber, Vice President of Sales for ETC Biomedical Systems, stated, "We are delighted with the continued success of Hospimedica in introducing the BARA-MED to India's Healthcare marketplace. We look forward to working closely with them and their clients for many years to come."

ETC is the world leader in automated monoplace hyperbaric chambers which include a 4th generation, time-honored computerized system. The BARA-MED(R) XD includes O.S.C.A.R. (TM) (Operating System for Control And Recordkeeping), giving you the benefit of patient comfort and safety, plus electronic medical recordkeeping (EMR).

With O.S.C.A.R. (TM) on your team, you eliminate the need for operator dive time management and paper recordkeeping while ensuring comprehensive documentation of the procedure. These features enable technicians to focus their attention on patient care and management, making your team more effective and efficient.

ETC chambers remain the leader in providing a patient friendly pressurization alternative (Smooth Ride(TM) ) that minimizes complications due to middle ear and sinus barotraumas without increasing compression time. In addition, with Smooth-Ride(TM) you obtain a smoother decompression which is important for patients with COPD.

ETC was incorporated in 1969 in Pennsylvania and this year we will celebrate our 40th anniversary. Our core technologies include the design, manufacture and sale of Training Services (TSG) which includes (1) software driven products and services used to create and monitor the physiological effects of flight; (2) high performance jet tactical flight simulation, and; (3) driving and disaster simulation systems, and Control Systems (CSG) which includes: (1) steam and gas sterilization; (2) testing and simulation devices for the automotive industry, and; (3) hyperbaric and hypobaric chambers. Product categories included in TSG are Aircrew Training Systems (ATS) and flight simulators, disaster management systems and entertainment applications. CSG includes sterilizers, environmental control devices and hyperbaric chambers along with parts and service support.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ETC's current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC and its subsidiaries that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

These forward-looking statements include statements with respect to the Company's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of the company, including but not limited to, (i) potential additional funding by H.F. Lenfest, a member of our Board of Directors and a significant shareholder, and PNC Bank, (ii) the trading of the Company's common stock on the Over-the-Counter Bulletin Board (iii) projections of revenues, costs of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (iv) statements of our plans and objectives of the Company or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (v) statements of future economic performance, (vi) statements of assumptions and other statements about the Company or its business, (vii) statements made about the possible outcomes of litigation involving the Company, (viii) statements regarding the Company's ability to obtain financing to support its operations and other expenses, and (ix) statements preceded by, followed by or that include the words, "may," "could," "should," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond the Company's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in the Company's Annual Report on Form 10 K for the fiscal year ended February 27, 2009, in the section entitled "Risks Particular to Our Business." Shareholders are urged to review these risks carefully prior to making an investment in the Company's common stock.

The Company cautions that the foregoing list of important factors is not exclusive. Except as required by federal securities law, the Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

    Contact: Duane D. Deaner, CFO    Tel: 215-355-9100  (ext. 1203)
                                     Fax: 215-357-4000

    ETC - Internet Home Page:       http://www.etcusa.com


'/>"/>
SOURCE Environmental Tectonics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Environmental Tectonics Corporation Announces Promotion of Don R. Webber to VP of Sales for their BioMedical Division
2. Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test
3. Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
4. Environmental Tectonics Corporations BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting
5. Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan
6. Ten Top Latin American Scientists Named 2009 Pew Fellows in the Biomedical Sciences
7. NCIIA Honors Top Collegiate Biomedical Engineering Teams
8. The Foundation for Biomedical Research Wins Telly Award for Majestic
9. Biomedical Sciences Companies Expanding in Asia Invested More Than US$500 Million in Singapore
10. Adipose-derived Stem Cells Could Help Traumatic Brain Injury Patients, Says Bio-Matrix Scientific Groups, Entest BioMedical Inc. Researcher
11. Bio-Matrix Scientific Group & Entest BioMedical Submit Research Proposal to U.S. Army for Funding Adipose-Derived Stem Cells to Treat Traumatic Brain Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 30, 2016 , ... The MIT bioLogic design team has ... team explored how bacterial properties can be applied to fabric and formed into living ... move in response to humidity change. The team harvested Natto cells and applied them ...
(Date:4/29/2016)... ... 2016 , ... Amendia, Inc., a leading designer, developer, manufacturer ... completion of a significant transaction and partnership that positions Amendia for accelerated growth ... Kohlberg & Company, L.L.C. (“Kohlberg”), a leading private equity firm specializing in middle ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... to transform technology into a viable company, CereScan’s CEO, John Kelley, joined other ... a recognized leader and mentor in the Denver area business community, shared his ...
(Date:4/29/2016)... ... , ... Intelligent Implant Systems announced today that the two-level components for the ... United States. These components expand the capabilities of the system and allow Revolution™ ... October of 2015, the company has seen significant sales growth in 1Q 2016, and ...
Breaking Biology Technology:
(Date:3/14/2016)... , Allemagne, March 14, 2016 ... http://www.apimages.com ) - --> - Renvoi : ... - --> --> ... solutions biométriques, fournit de nouveaux lecteurs d,empreintes digitales ... LF10 de DERMALOG sera utilisé pour produire des ...
(Date:3/9/2016)... YORK , March 9, 2016 This ... and future states of the RNA Sequencing (RNA Seq) ... segments such as instruments, tools and reagents, data analysis, ... Analyze various segments of the RNA-Sequencing market such as ... services Identify the main factors affecting each segment and ...
(Date:3/3/2016)... , March 3, 2016  2016FLEX, organized ... this week highlighting advancements in flexible, hybrid and ... record setting attendance - have gathered for short ... fast-growing field of electronics. The Flex Conference celebrates ... point for companies, R&D organizations, and universities contributing ...
Breaking Biology News(10 mins):